Flow cytometric DNA ploidy, p53, PCNA, and c-erbB-2 protein expressions as predictors of survival in surgically resected gastric cancer patients

Communications in Clinical Cytometry

Volumn 42, Issue 1, 2000, Pages 27-34

  Danesi, Donatella Tirindelli ^a   Spanò, Marcello ^a   Fabiano, Alfredo ^b   Altavista, Pierluigi ^a   Pasqualetti, Patrizio ^b   Toscano, Maria Gabriella ^b   Antonini, Fabiana ^b   Catalano, Piera ^b   Mecozzi, Antonella ^b   Picconi, Antonello ^b   Daffinà, Antonio ^b   Cucchiara, Giuseppe ^b  

^a ENEA C R CASACCIA   (Italy)

^b FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

c erbB 2; DNA flow cytometry; Gastric cancer; p53; PCNA

Indexed keywords

CYCLINE; DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; DNA CONTENT; FEMALE; FLOW CYTOMETRY; GASTRECTOMY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE C ERB; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DNA; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ERBB-2; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034652606     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(20000215)42:1<27::AID-CYTO5>3.0.CO;2-N     Document Type: Article

References (48)

1. Abad M, Ciudad J, Rincon MR, Silva I, Paz-Bouza JI, Lopez A, Alonso AG, Bullon A, Orfao A. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer. Anal Cell Pathol 1998;16:223-231.
2. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34: 187-220.
3. D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A, Zupi G. DNA ploidy proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest 1995;72:432-438.
4. Duhaylongsod FG, Gottfried MR, Iglehart JD, Vaughn AL, Wolfe VG. The significance of c-erbB-2 and p53 immunoreactivity in patients with adenocarcinonia of the esophagus. Ann Surg 1995;221:677-683.
5. Flyger HL, Christensen IJ, Thorup J, Hakansson TV, Norgaard T. DNA aneuploidy in gastric carcinoma: flow cytometric data related to survival, location, and histopathological findings. Scand J Gastroenterol 1995;30:258-264.
6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrove EA. Method for analysis of cellular DNA content in paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31:1333-1335.
7. Hedley DW, Friedlander ML, Taylor IW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical relevance. Cytometry 1985;6:327-333.
8. Heiden T, Wang N, Tribukait B. An improved Hedley method for preparation of paraffin embedded tissues for flow cytometric analysis of ploidy and S-phase. Cytometry 1991;12:614-621.
9. Hermanek P, Sobin LH. UICC. TNM classification of malignant tumours. Heidelberg: Springer-Verlag: 1992. p 43-46
10. Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako H, Van De Velde CJ. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11: 1441-1447.
11. Hilton DA, West KP. c-erbB-2 oncogene product expression and prognosis in gastric carcinoma. J Clin Pathol 1992;45:454-456.
12. Kallioniemi OP. Comparison of fresh and paraffin-embedded tissue as starting material for DNA How cytometry and evaluation of intratumor heterogeneity. Cytometry 1988;9:164-169.
13. Kelsen DP. Adjuvant therapy of upper gastrointestinal tract cancers. Semin Oncol 1995;22:582-599.
14. Kim JH, Uhm HD, Gong SJ, Shin DH, Choi JH, Lee HR, Noh SH, Kim BS, Cho JY, Rha SY, Yoo NC, Chung HC, Roh JK, Min JS, Lee KS, Kim BS. Relationship between p53 overexpression and gastric cancer progression. Oncology 1997;54:166-170.
15. Kimura H, Yonemura Y. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis. Cancer 1991;67:2588-2593.
16. Korenaga D, Okamura T, Saito A, Baba H, Sugimachi K. DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer. Cancer 1988;62:309-313.
17. Lee HR, Kim JH, Uhm JB, Ahn JB, Rha SY, Cho JY, Lee KH, Chung HC, Roh JK, Min JS, Lee KS, Shin DH, Kim BS, Hong SW, Choi JH. Overexpression of c-crbB-2 protein in gastric cancer by immunohistochemical stain. Oncology 1996;53:192-197.
18. Lee KH, Lee JS, Suh C, Ahn MJ, Kim SW, Doh BS, Min YI, Kim BS, Park KC, Lee IC, Cho YJ, Choi MG, Kim S. DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings. Cancer 1993;72:1819-1826.
19. Leong ASY. Microwave techniques for diagnostic laboratories. Scanning 1993;15:88-98.
20. Macartney JC, Camplejohn RS, Powell G. DNA flow cytometry of histological material from human gastric cancer. J Pathol 1986;148: 273-277.
21. Machara Y, Tomoda M, Kahashima A, Tokunaga K, Kakeji Y, Sukimachi K. Prognostic value of p53 protein expression for patients with gastric cancer - a multivariate analysis. Br J Cancer 1999;79:1255-1261.
22. Mangham DC, Rowlens DC, Newbold KM, Reynolds GM, Fielding JWL, Hallissey MT. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value. J Clin Pathol 1994;47:473-474.
23. Maturri L, Biondo B, Cazzullo A, Colombo B, Giordano F, Guarino M, Pallotti F, Turconi P, Lavezzi AM Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyo-type) in 126 adenocarcinoma gastric biopsies. Anticancer Res 1998; 18:2819-2826.
24. Mori M, Kakeji Y, Adachi Y, Moriguchi S, Maehara Y, Sugimachi K, Jessup JM. Chen LB, Steele GD. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery 1993; 113:683-690.
25. Müller W, Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol 1996;178:255-258.
26. Nanus DM, Kelsen DP, Niedzwiecki D, Chapman D, Brennan M, Cheng E, Melamed M. Flow cytometry as a predictive indicator in patients with operable gastric cancer. J Clin Oncol 1989;7:1105-1112.
27. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999;85:1894-1902.
28. Ohyama S, Yonemura Y, Miyazaki I. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Cancer 1990;65:116-121.
29. Ohyama S, Yonemura Y, Miyazaki I. Proliferative activity and malignancy in human gastric cancers. Cancer 1992;69:314-321.
30. Rose DSC, Maddox PH, Brown DC. Which proliferation marker for routine immunohistology? A comparison of five antibodies. J Clin Pathol 1994;47:1010-1014.
31. Rugge M, Sonego F, Panozzo M, Baffa R, Rubio J, Farinati F, Nitti D, Ninfo V, Si-Chun M. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer 1994;73:1127-1132.
32. Sakusabe M, Kodama M, Sato Y, Kikuchi T, Koyama K. Clinical significance of DNA ploidy pattern in stage III gastric cancer. World J Surg 1996;20:27-31.
33. Setala L, Kosma VM, Lipponen P, Naukkarinen A, Nordling S, Hollmen S, Eskelinen M, Syrjanen K, Alhava E. Clinical relevance of p53 index and expression of proliferating cell nuclear antigen and KI-67 in gastric cancer. J Cancer Res Clin Oncol 1998;124:497-502.
34. Setala LP, Nordling S, Kosma V, Lipponen PK, Eskelinen MJ, Hollmén SM, Syrjanen KJ, Alhava EM. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer. Anal Quant Cytol Histol 1997;19:524-532.
35. Shankey TV, Rabinovitch PS, Bagwell B, Bauer KD, Duque RE, Hedley DW, Mayall BH, Wheeless L, Cox C. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-477.
36. Shiroko T, Saji S, Kawaguchi Y, Kunieda K, Unemoto T. A study on the relationship between clinicopathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53, and nm23. Gan To Kagaku Ryoho 1995;22:118-123.
37. Songun I, Velde CJH van de, Hermans J, Pals ST. Vaerspaget HV, Vis AN, Menon AG, Litvinov SV, van Krieken JHJM. Expression of oncoproteins and the amount of eosinophilic and lymphocytic infiltrates can be used as prognostic factors in gastric cancer. Br J Cancer 1996;74:1783-1788.
38. Soong R, Robbins PD, Dix BR, Grieu F, Lim B, Knowles S, Williams KE, Turbett GR, House AK, Iacopetta BJ. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996;27:1050-1055.
39. Sumner BEH. Basic histochemistry. Chichester: John Wiley & Sons; 1988. p 69-80.
40. Takamura H, Yonemura Y, Fonseca L, Ninomiya I, Tsugawa K, Miwa K, Miyazaki I. Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas. Nippon Geka Gakkai Zasshi 1995;96:213-222.
41. Danesi DT, Spanò M, Antonini F, Altavista P, Catalano P, Cordelli E, Pasqualetti P, Santacroce C, Toscano MB, Mecozzi A, Fabiano A. Flow cytometric and immunohistochemical correlations in high incidence solid tumors. Tumori 1997;83:689-697.
42. Tokunaga A, Onda M, Okuda T, Teramoto T, Fujita I, Mizutani T, Kiyama T, Yoshiyuki T, Nishi K, Matsukura N. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. Cancer 1995;75:1418-1425.
43. Victorzon M, Roberts PJ, Haglund C, Von Boguslawsky K, Nordling S. Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 1996;53:182-191.
44. Wang Z, Ikeguchi M, Maeta M, Kaibara N. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa. Anticancer Res 1997;17:3701-3706.
45. Wyatt JI, Quirke P, Ward DC, Clayden AD, Dixon MF, Johnston D, Bird CC. Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer. J Pathol 1989; 158:195-201.
46. Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, Kosaka T, Yamaguchi A, Miwa K, Miyazaki I. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Cancer Res 1990;50:509-514.
47. Yonemura Y, Fonseca L, Tsugawa K, Ninomiya I, Matsumoto H, Sugiyama K, Ohoyama S, Fushida S, Kimura H, Miyazaki I. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer. Oncology 1994;51:251-257.
48. Yonemura Y, Ninomiya I, Tsugawa K, Fushida S, Fujimura T, Miyazaki I, Uchibayashi T, Endou Y, Sasaki T. Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach. Cancer Detect Prev 1998;22:139-146.